Bruce Cheson, MD, Professor of Medicine, Head of Hematology, and Director of Hematology Research at the Lombardi Comprehensive Cancer Center at Georgetown University Hospital, has been elected Chair of the Lymphoma Research Foundation Scientific Advisory Board, a two-year term that began July 1. Dr. Cheson is also Editor-in-Chief of the journals Clinical Lymphoma, Myeloma & Leukemia and Clinical Advances in Hematology and Oncology.
“We are pleased to have Dr. Cheson take on this important role,” said LRF CEO Diane Blum, MSW. “He has generously given of his time to the Foundation for many years, holding a variety of leadership roles and bringing a wealth of experience to the position. He is a visionary leader, and his insight and skills will prove invaluable.”
Kathleen Egan, PhD, senior member of the Risk Assessment, Detection, and Intervention Program at Moffitt Cancer Center, has received a $2.2 million grant from the National Cancer Institute to develop a postdoctoral training program in molecular and genetic epidemiology. The training program will provide a specialized curriculum to prepare academic researchers to integrate the latest technologies and full spectrum of outcomes in molecular and genetic epidemiology. The grant also provides for training of eight postdoctoral fellows over five years.
The American Association for Cancer Research has received four Telly Awards for its “It's Our Time” video. The five-minute video, which premiered at the Opening Ceremony of AACR's 101st Annual Meeting this spring and dramatically shows the statistics on the progress and promise of cancer research, won a silver award (the highest honor) in the Charitable/Not-for Profit category, and three bronze awards in the categories of Education, Motivational, and Use of Animation.
The awards honor the best local, regional, and cable TV commercials and programs, as well as video and film productions and work created for the Web, with the stated aim of strengthening the visual arts community by inspiring, promoting, and supporting creativity. This year's competition received approximately 11,000 entries.
The video can be seen at http://bit.ly/cedJWv
Researchers at the University of Colorado have launched the Cancer Stem Cell-Directed Clinical Trials Program (CCTP), the nation's first program focused on identifying and testing drugs that target and destroy cancer stem cells. CCTP is a collaboration between the University of Colorado Cancer Center (UCCC) and the Charles C. Gates Center for Regenerative Medicine and Stem Cell Biology, both located at the University of Colorado School of Medicine. The program will be directed by head and neck specialist AntonioJimeno, MD, PhD, along with senior co-directors DennisRoop, PhD, Gates Stem Cell Center Director and Professor of Dermatology at the School of Medicine, and S. GailEckhardt, MD, UCCC Deputy Director, Head of Medical Oncology at the medical school and leader of UCCC's early-phase cancer clinical trials program.
The Cancer Research Institute, Inc. has named three cancer scientists as the joint recipients of its 2010 William B. Coley Award for Distinguished Research in Basic and Tumor Immunology, recognizing their contributions to the understanding of the prognostic significance of infiltrating T lymphocytes in cancer patients. The awardees are HaruoOhtani, MD, Director of the Department of Pathology at Mito Medical Center, National Hospital Organization, Ibaraki, Japan; WolfHervéFridman, MD, PhD, Professor of Immunology and Vice Dean for Research, Medical School Paris Descartes, Director of the Cordeliers Research Centre, and head of the Service of Immunology, Hospital European Georges Pompidou, Paris, France; and JérômeGalon, PhD, Research Director for INSERM [Institut National de la Santé et de la Recherche Médicale (National Institute of Health and Medical Research)] and head of the Integrative Cancer Immunology Laboratory at Cordeliers Research Center in Paris.
Johns Hopkins Kimmel Cancer Center has received a $20 million gift for pancreas cancer research from Rydex Investments founder and former Hopkins pancreas cancer patient Albert P. “Skip” Viragh, Jr., who died of the disease at age 62. The funds formally establish the Skip Viragh Center for Pancreas Cancer Clinical Research and Patient Care, expanding the pancreas cancer laboratory as well as the internationally recognized clinical programs there. A new website, launched with the gift, www.hopkinsmedicine.org/pancreascancer, also contains information about pancreas cancer treatment and research at the center.
Margaret M. Fields, APN, an advanced practice nurse in The University of Texas M. D. Anderson Cancer Center's Department of Gynecologic Oncology, has received the 2010 Ethel Fleming Arceneaux Outstanding Nurse-Oncologist Award, made possible by the Brown Foundation, Inc. Dr. Fields plays an integral part in M. D. Anderson's gynecologic oncology outreach site at Lyndon B. Johnson General Hospital, providing underserved patient populations access to clinical trials of potential new therapies, improved patient care, and psychosocial support.
At the M. D. Cancer Center Orlando, ChadKollas, MD, Medical Director of the Department of Palliative and Support Care, has been appointed Acting Vice-Chair of the AMA's Pain and Palliative Medicine Specialty Section Council; and internist MilesLota, DO, has joined the Department of Cancer Medicine to assist oncology patients with certain side effects of cancer treatment.
Gretchen McNally, PhD, CNP, a nurse practitioner on the hematology service at Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, has been named “Woman of the Year” by the Central Ohio Chapter of the Leukemia & Lymphoma Society. Dr. McNally and her team of nurses, nurse practitioners, patient care associates, pharmacists, and leukemia survivors raised approximately $31,000 for the society in 10 weeks in honor of a local eight-year-old boy who was diagnosed with acute lymphoblastic leukemia in 2006. In total, the nine central Ohio candidates for the award raised more than $160,000 for cancer research and patient services.
The Oncology Nursing Certification Corporation named KarenRoesser, RN, MS, AOCN, oncology clinical nurse specialist/genetic educator at Thomas Johns Cancer Hospital in Richmond, VA, the 2010 Advanced Oncology Certified Nurse of the Year; and Robin Stewart, RN, PhD, OCN, Clinical Research Manager, Lakeland Regional Medical Center, Lakeland, FL, Oncology Certified Nurse of the Year, at the Oncology Nursing Society Annual Congress. Employer Recognition Awards were also presented to Mid Florida Hematology/Oncology Centers, Orange City, FL, recognizing an employer of fewer than 25 nurses that provides sustained support of oncology nursing certification; and Saint Vincent Medical Center, Erie, PA, for an organization employing 25 or more registered nurses.
KunleOdunsi, MD, PhD, has been appointed Chair of the Department of Gynecologic Oncology at Roswell Park Cancer Institute (RPCI). Dr. Odunsi will also assume leadership of the newly created Center for Immunotherapy at RPCI. The good-manufacturing-practice facility, currently in development, will be used for the production of clinical vaccines, antibodies, and cellular products, and will support clinical immunotherapy trials. Dr. Odunsi succeeds ShashikantLele, MD, who has been named Clinical Chief of Gynecologic Oncology and Executive Director of Practice Development at RPCI.
Joshua Raff, MD, has been appointed Section Chief of Hematology and Oncology at White Plains Hospital Center. Dr. Raff has been an active member of the medical staff at White Plains Hospital Center since 2003 and is a partner of Oncology and Hematology of White Plains. He also serves as Chairman of the Gastrointestinal Cancer Conference for the GI Cancer Program at Dickstein Cancer Center.
PeterRavdin, MD, PhD, has been named Director of the Breast Health Clinic at the Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio. Dr. Ravdin joined the Health Science Center faculty in March, after working independently for eight years, during which time he developed Adjuvant!, the widely used online tool that estimates the benefits and risks of chemotherapy after breast cancer surgery. Dr. Ravdin was also previously a member of the Health Science Center faculty from 1987 until 2002, serving in multiple capacities.
Engineer Ronald Nutt, PhD, and physicist David William Townsend, PhD, have received the 2010 IEEE (Institute of Electrical and Electronics Engineers) Medal for Innovations in Healthcare Technology for their invention of the hybrid positron emission tomography/computed tomography scanner. Both IEEE fellows, Dr. Nutt is co-founder of CTI Molecular Imaging, and Dr. Townsend heads PET and SPECT (single photon emission computed tomography) development for the Singapore Bioimaging Consortium at the National University of Singapore. The duo created the PET/CT scanner in 1999.
UNC Lineberger Comprehensive Cancer Center has appointed Lisa Carey, MD, and NedSharpless, MD, to lead and develop strategic priorities as the center expands clinical programs in the new North Carolina Cancer Hospital, as well as research initiatives among its faculty. As Associate Director for Clinical Science, Dr. Carey, former Associate Professor of Medicine, Medical Director of the UNC Breast Center, and Co-leader of UNC Lineberger's Breast Cancer Program, will be responsible for promoting clinical sciences across all cancer programs with a particular emphasis on developing clinical trials. Dr. Sharpless, a UNC-Chapel Hill Morehead Scholar, will serve as Associate Director for Translational Research, promoting and integrating pre-clinical translational activities.
AmiVaidya, MD, has joined the Division of Gynecologic Oncology at John Theurer Cancer Center at Hackensack University Medical Center. Dual-board certified in gynecologic-oncology and obstetrics-gynecology, Dr. Vaidya comes to John Theurer from the Cancer Institute of New Jersey, University of Medicine and Dentistry of New Jersey–Robert Wood Johnson Medical School, where she served as Assistant Professor of Obstetrics and Gynecology.
Sanford I.Weill has received the 2010 James Ewing Layman's Award from the Society of Surgical Oncology in honor of his support in advancing cancer care. Mr. Weill, Chairman of the Board of Overseers of Weill Cornell Medical College, and his wife, Joan, have donated some $800 million to organizations, including Weill Cornell Medical College; Memorial Sloan-Kettering Cancer Center; Sidra, a teaching hospital to be completed at the Medical College's Qatar campus in 2012; and Weill Bugando Medical Centre in Tanzania, one of Africa's top physician training programs.© 2010 Lippincott Williams & Wilkins, Inc.
More on ONCOLOGY-TIMES.com...